| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |